CAS 2026635-66-3

GNE 5729

CAS : 2026635-66-3

GNE 5729

Degré de pureté : ≥98%

Masse moléculaire : 428.2g/mol

Ref: 54-BUP21394

(1R,2R)-2-(7-Chloro-2-((5-chloro-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-6-yl)cyclopropane-1-car bonitrile

CAS : 2026635-66-3

(1R,2R)-2-(7-Chloro-2-((5-chloro-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-6-yl)cyclopropane -1-carboxylic acid is an antiviral drug that inhibits the replication of a wide range of RNA viruses. It has been shown to inhibit several ion channels and protein interactions with high purity. (1R,2R)-2-(7-Chloro-2-(5 chloro 3-(trifluoromethyl)-1H pyrazol 1 yl)methyl 4 oxo 4H pyrido 1 2 a pyrimidin 6 yl) cyclopropanecarboxylic acid is used as a research tool in pharmacology and cell biology.

Formule : C₁₇H₁₀Cl₂F₃N₅O

Degré de pureté : Min. 95%

Masse moléculaire : 428.2 g/mol

Ref: 3D-BGD63566

GNE-5729

CAS : 2026635-66-3

GNE-5729 is a positive allosteric modulator of NMDAR blood-brain barrier orally available, GluN2A, GluN2C and GluN2D, neurological and psychiatric disorders.

Formule : C₁₇H₁₀Cl₂F₃N₅O

Degré de pureté : 99.40% - 99.85%

Couleur et forme : Solid

Masse moléculaire : 428.2

Ref: TM-T15408